Twist Bioscience Corporation
Stock Details
Is it expensive?
Trailing P/E Ratio
-38.59
Forward P/E Ratio
-26.64
PEG Ratio
6.82
-26.55
Price-to-Sales (TTM)
7.86
6.75
7.44
Market Cap
3.07B
2.99B
Is it profitable?
Net Profit Margin (TTM)
-19.56%
Gross Profit Margin
52.05%
Diluted EPS (TTM)
-1.27
-16.79%
391.56M
Is it growing?
16.90%
16.89%
Is it risky?
2.21
24.79
3.78
113.05M
Who owns it?
122.62%
1.52%
27.04%
61.27M
54.65M
Does it pay?
0.00%
0.00%
--
--
How much cash?
197.95M
-51.01M
-47.24M
3.23
- Price
- 51.17
- Percent Change
- +1.05 (2.09%)
- Previous Close
- 50.12
- Open
- 53.52
- Low
- 50.83
- High
- 54.19
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$51.17
From 52W Low
+119.61%
From 52W High
-11.59%
Today
+2.09%
1Y Change
+27.07%
6M
$31.89
3M
$35.32
1M
$48.33
Today
$51.17
From 52W Low
+119.61%
From 52W High
-11.59%
Today
+2.09%
1Y Change
+27.07%
6M
$31.89
3M
$35.32
1M
$48.33
Today
$51.17
Expensive
within its 1-year price range
$51.17
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+5.9%
3M
+44.9%
6M
+60.5%
1Y
+27.1%
Rate of Change (ROC)
Decelerating
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Twist Bioscience Corporation
- Founded
- Jan 1, 2013
- Founders
- Dr. Emily Marine Leproust Ph.D., Bill Peck, Chee-Ghee Lee
- CEO
- Emily Marine Leproust
- Employees
- 979
- Fiscal Year End
- Sep 30, 2025
- Address
681 Gateway Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.twistbioscience.com
Indicators
Operating Cash Flow
-51.01M
Net Income
-76.58M
Mixed Signal
0.67
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
-51.01M
Net Income
-76.58M
Mixed Signal
0.67
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-38.59
Forward P/E Ratio
-26.64
PEG Ratio
6.82
-26.55
Price-to-Sales (TTM)
7.86
6.75
7.44
Market Cap
3.07B
2.99B
Is it profitable?
Net Profit Margin (TTM)
-19.56%
Gross Profit Margin
52.05%
Diluted EPS (TTM)
-1.27
-16.79%
391.56M
Is it growing?
16.90%
16.89%
Is it risky?
2.21
24.79
3.78
113.05M
Who owns it?
122.62%
1.52%
27.04%
61.27M
54.65M
Does it pay?
0.00%
0.00%
--
--
How much cash?
197.95M
-51.01M
-47.24M
3.23
- Price
- 51.17
- Percent Change
- +1.05 (2.09%)
- Previous Close
- 50.12
- Open
- 53.52
- Low
- 50.83
- High
- 54.19
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$51.17
From 52W Low
+119.61%
From 52W High
-11.59%
Today
+2.09%
1Y Change
+27.07%
6M
$31.89
3M
$35.32
1M
$48.33
Today
$51.17
From 52W Low
+119.61%
From 52W High
-11.59%
Today
+2.09%
1Y Change
+27.07%
6M
$31.89
3M
$35.32
1M
$48.33
Today
$51.17
Expensive
within its 1-year price range
$51.17
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+5.9%
3M
+44.9%
6M
+60.5%
1Y
+27.1%
Rate of Change (ROC)
Decelerating
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Twist Bioscience Corporation
- Founded
- Jan 1, 2013
- Founders
- Dr. Emily Marine Leproust Ph.D., Bill Peck, Chee-Ghee Lee
- CEO
- Emily Marine Leproust
- Employees
- 979
- Fiscal Year End
- Sep 30, 2025
- Address
681 Gateway Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.twistbioscience.com